Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is based in Kingsgrove, Australia.
Research context
Cyclopharm Limited appears in PyInvesting’s Australia Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Cyclopharm Limited is currently in a long term downtrend where the price is trading 34.4% below its 200 day moving average.
From a valuation standpoint, the stock is 94.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 13.3.
Cyclopharm Limited's total revenue rose by 17.6% to $9M since the same quarter in the previous year.
Its net income has dropped by 451.4% to $-394K since the same quarter in the previous year.
Finally, its free cash flow fell by 118.9% to $-3M since the same quarter in the previous year.
Based on the above factors, Cyclopharm Limited gets an overall score of 2/5.